UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 588

Sortiert nach

Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature

Dementia and geriatric cognitive disorders, 2008-02, Vol.25 (2), p.115

2008

Volltextzugriff (PDF)

Tau-related white-matter alterations along spatially selective pathways

NeuroImage (Orlando, Fla.), 2021-02, Vol.226, p.117560-117560, Article 117560

2021

Volltextzugriff (PDF)

Hippocampal Atrophy and Ventricular Enlargement in Normal Aging, Mild Cognitive Impairment (MCI), and Alzheimer Disease

Alzheimer disease and associated disorders, 2012, Vol.26 (1), p.17-27

2012

Volltextzugriff (PDF)

APOE ε4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD

Alzheimer's & dementia, 2023-05, Vol.19 (5), p.2212-2217

2023

Volltextzugriff (PDF)

Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal

Neurobiology of aging, 2010-07, Vol.31 (7), p.1077-1088

2010

Volltextzugriff (PDF)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2019-12, Vol.11 (1), p.510-519

2019

Volltextzugriff (PDF)

Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment

Neuropsychologia, 2008-01, Vol.46 (6), p.1597-1612

2008

Volltextzugriff (PDF)

Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance

Alzheimer's & dementia, 2015-02, Vol.11 (2), p.126-138

2015

Volltextzugriff (PDF)

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

Alzheimer's research & therapy, 2012-01, Vol.4 (5), p.43-43

2012

Volltextzugriff (PDF)

Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer’s disease

Cell reports (Cambridge), 2024-02, Vol.43 (2), p.113691-113691, Article 113691

2024

Volltextzugriff (PDF)

White matter alterations in early-stage Alzheimer's disease: A tract-specific study

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2019-12, Vol.11 (1), p.576-587

2019

Volltextzugriff (PDF)

Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease

Neurobiology of disease, 2018-06, Vol.114, p.120-128

2018

Volltextzugriff (PDF)

Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease

Dementia and geriatric cognitive disorders, 2014-01, Vol.37 (5-6), p.315

2014

Volltextzugriff (PDF)

Effects of risk factors on the development and mortality of early- and late-onset dementia: an 11-year longitudinal nationwide population-based cohort study in South Korea

Alzheimer's research & therapy, 2024-04, Vol.16 (1), p.92-11, Article 92

2024

Volltextzugriff (PDF)

Widespread white matter and conduction defects in PSEN1- related spastic paraparesis

Neurobiology of aging, 2016-11, Vol.47, p.201-209

2016

Volltextzugriff (PDF)

Resting state network modularity along the prodromal late onset Alzheimer's disease continuum

NeuroImage clinical, 2019-01, Vol.22, p.101687-101687, Article 101687

2019

Volltextzugriff (PDF)

Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment

Dementia and geriatric cognitive disorders extra, 2019-05, Vol.9 (2), p.281-293

2019

Volltextzugriff (PDF)

Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer's disease

Alzheimer's research & therapy, 2021-06, Vol.13 (1), p.113-113, Article 113

2021

Volltextzugriff (PDF)

Donanemab in Early Alzheimer’s Disease

The New England journal of medicine, 2021-05, Vol.384 (18), p.1691-1704

2021

Volltextzugriff (PDF)

Predicting the Emergence of Major Neurocognitive Disorder Within Three Months After a Stroke

Frontiers in aging neuroscience, 2021-08, Vol.13, p.705889-705889

2021

Volltextzugriff (PDF)

Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis

Alzheimer's research & therapy, 2020-08, Vol.12 (1), p.93-93, Article 93

2020

Volltextzugriff (PDF)

Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity

Dementia and geriatric cognitive disorders, 2020-02, Vol.48 (3-4), p.131

2020

Volltextzugriff (PDF)

Relationship between hippocampal atrophy and neuropathology markers: A 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol

Alzheimer's & dementia, 2015-02, Vol.11 (2), p.139-150

2015

Volltextzugriff (PDF)

Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics

Brain (London, England : 1878), 2023-11, Vol.146 (11), p.4414-4424

2023

Volltextzugriff (PDF)

New insights into atypical Alzheimer's disease in the era of biomarkers

Lancet neurology, 2021-03, Vol.20 (3), p.222-234

2021

Volltextzugriff (PDF)

1 – 25 von 588

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(569)
Mit Volltextzugriff
(537)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature

Tau-related white-matter alterations along spatially selective pathways

Hippocampal Atrophy and Ventricular Enlargement in Normal Aging, Mild Cognitive Impairment (MCI), and Alzheimer Disease

APOE ε4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD

Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition

Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment

Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer’s disease

White matter alterations in early-stage Alzheimer's disease: A tract-specific study

Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease

Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease

Effects of risk factors on the development and mortality of early- and late-onset dementia: an 11-year longitudinal nationwide population-based cohort study in South Korea

Widespread white matter and conduction defects in PSEN1- related spastic paraparesis

Resting state network modularity along the prodromal late onset Alzheimer's disease continuum

Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment

Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer's disease

Donanemab in Early Alzheimer’s Disease

Predicting the Emergence of Major Neurocognitive Disorder Within Three Months After a Stroke

Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis

Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity

Relationship between hippocampal atrophy and neuropathology markers: A 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol

Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics

New insights into atypical Alzheimer's disease in the era of biomarkers

Suchergebnisse filtern